Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery. - Pretorius M; Murray KT; Yu C; Byrne JG; Billings FT 4th; Petracek MR; Greelish JP; Hoff SJ; Ball SK; Mishra V; Body SC; Brown NJ; et al. (Critical Care Medicine, 2012)